Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATPase copper transporting beta pseudogene 1 (ATP7BP1) is a non-protein-coding locus classified as a pseudogene, which means it shares sequence similarity with functional copper-transporting ATPase genes but has lost the ability to encode a functional protein due to disabling mutations[1][5]. Unlike its protein-coding relatives, such as ATP7B or ATP7A, ATP7BP1 does not carry out copper ion transport[1][5]. Pseudogenes are typically considered non-functional remnants, though emerging evidence in the pseudogene field suggests some pseudogenes may play non-coding regulatory roles, mainly through RNA-mediated mechanisms impacting expression of related genes in select cases[2][3][4]. No such function or disease association has been described for ATP7BP1. It is located on chromosome 18q11.2[5]. If you need structured database fields, this information allows accurate mapping to canonical form while flagging that this entry is a non-functional pseudogene, not a molecular therapeutic target, and contains no actionable drug or biomarker information.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATPase copper transporting beta pseudogene 1 (ATP7BP1).